WHAT WE DO

Founded by a team with deep scientific knowledge and business experience, Heptech emerged to tackle pressing health challenges with real-world impact.

Driven by a passion for scientific discovery, Heptech is committed to promoting R&D and scientific innovation leading to the creation of new heparin-derived products.

We conduct rigorous product testing to ensure compliance with pharmacopeia quality standards, streamline process optimization, and assist in sales through expert technical support.

At Heptech, we are passionate about delivering excellence in all that we do.

We are committed to discovering and developing innovative heparin-derived products.

Explore the possibilities of these pioneering advancements.

OUR TEAM

Rafael Aquino

More info

Rafael Aquino

CEO

LinkedIn
Rafael Aquino

Rafael Aquino

CEO

Rafael Aquino, PhD, MBA, holds extensive expertise as a glycobiologist, senior research project manager, and innovation specialist. He plays a crucial role in overseeing the company's daily operations and in guiding its strategic direction. Before joining Heptech, Rafael served as a Project Manager at the Getulio Vargas Foundation (FGV) think tank, where he led a variety of public health projects. Previously, he was a Senior Researcher at Hygeia Biotech, focusing on drug discovery, product development, and technology transfer for the Brazilian pharmaceutical industry. Rafael earned his PhD and Master's degree in Biochemistry, along with an MBA from COPPEAD at the Federal University of Rio de Janeiro. He also completed a postdoctoral fellowship at Harvard Medical School, further enhancing his expertise in the field.

Eduardo Vilanova

More info

Eduardo Vilanova

Scientific Director, SBH

LinkedIn
Eduardo Vilanova

Eduardo Vilanova

Scientific Director, SBH

Eduardo Vilanova, PhD, is a highly skilled biologist/biochemist with a strong focus on the research and development of innovative heparin-based products. With a wealth of experience in the field, he has made significant contributions that have advanced scientific knowledge and driven advancements in the industry. Eduardo holds a Master's and PhD degree from UFRJ (Federal University of Rio de Janeiro) and has completed a postdoctoral program at the Instituto de Bioengenharia de Catalunya in Spain. During his postdoctoral research, he conducted cutting-edge studies that have been published in prestigious international journals. These publications not only showcase his dedication to scientific excellence but also highlight his valuable insights into the field of heparin research. Additionally, Eduardo brings valuable industry experience to his role at Heptech. Prior to joining our team, he worked at the biotech accelerator Biozeus, where he analyzed and conducted drug discovery projects. This experience has nurtured his passion for innovation, which remains a driving force in his work.

Stephan Marcin

More info

Stephan Marcin

Scientific Director, B-LMWH

LinkedIn
Stephan Marcin

Stephan Marcin

Scientific Director, B-LMWH

Stephan Oliveira, PhD, is an industrial pharmacist with extensive expertise in the landscape of heparin-related products. With a solid educational background, including two post-doctorates from UFRJ, he worked for over 10 years with antithrombotic and antitumor agents, bringing a wealth of knowledge and experience to his role at Heptech. Throughout his career, he also served as a professor at UFRJ, worked in hospital settings, and dealt with high-cost medications at the State Department. Additionally, he held various management positions in his military career. With a lifetime dedicated to heparin analysis and new product development, he is recognized for his profound understanding of quality requirements and standards in the pharmaceutical industry, actively collaborating in this context.

Ana Lucia Selvatici

More info

Ana Lucia Selvatici

Business Operations Director

LinkedIn
Ana Lucia Selvatici

Ana Lucia Selvatici

Business Operations Director

Ana Selvatici, BSc, MBA, brings extensive experience in new business development, marketing, and innovation to her role at Heptech. With a proven track record at companies such as Diagonal Minds, Globo Group and Oi, she excels in marketing strategies and management, business operation, and business transformation. Ana is skilled in managing teams to achieve strategic goals. She holds a degree in economics from UFRJ, an Executive MBA from COPPEAD, a postgraduate degree in Corporate Finance from PUC-RJ, and specializations in Analytical Marketing from Insper and Negotiation Techniques from HBX (Harvard Business School).

Urban Skog

More info

Urban Skog

Advisor

LinkedIn
Urban Skog

Urban Skog

Advisor

Urban is an executive with 35 years of experience in the biopharmaceutical industry. His career includes senior positions in local and global marketing and medical affairs, followed by 25 years of general management responsibilities in Roche and AstraZeneca in Europe, Latin America, and the US. Strengths include understanding the value of science in the clinical setting, building strategy and translation into impactful execution and leadership development. Communication and sharing of thoughts are key priorities.

ABOUT US

At Heptech, we are committed to discovering, developing, and delivering innovative, safe, high-quality, and effective heparin-derived products to meet the clinical medicine unmet needs and shortage risks of patients worldwide. In addition, we provide exceptional Quality Control and Sales services to ensure that our customers receive the best possible experience and support.

We aim to be recognized globally as a leading pharmaceutical company that uses science-based innovation to provide the best possible treatment options for patients in need.

  • Integrity: We adhere to the highest ethical standards when producing and delivering our products, ensuring their safety, quality, and effectiveness.
  • Customer Focus: We put our customers' needs first, always striving to exceed their expectations by providing superior products and services.
  • Accountability: We take personal responsibility for our actions, ensuring that we deliver on our promises and commitments.
  • Collaboration: We work together as a team, embracing diversity and transcending boundaries to achieve excellence in everything we do.
  • Community: We believe in making a positive impact on people's lives, both by protecting the environment and by contributing to the communities in which we operate.

PARTNERS

CONTACT

    Rua Real Grandeza, 82, Casa 4, Botafogo, Rio de Janeiro, RJ. CEP: 22281-034

    +55 (21) 98845-4284

    heptech@heptech.com.br

    Heptech